From biotech to defense, here are 10 top stock picks for 2026 from UBS

Core Insights - UBS has released its list of highest conviction stocks for 2026, focusing on companies across various sectors that are expected to outperform the broader market [1][3] Company Summaries - Acadia Pharmaceuticals (Ticker: ACAD) - Expected return for 2025 is +46% - The company is viewed positively due to its management's execution on growth initiatives for new drugs, particularly the upcoming trial results for ACP-204 related to Alzheimer's disease psychosis, expected in mid-2026 [4] - Alliant Energy Corp (Ticker: LNT) - Expected return for 2025 is +11% - The company is considered undervalued and is likely to benefit from the ongoing data center boom in 2026, with expectations of 2-4GW of upside opportunities [5][6] - Amazon (Ticker: AMZN) - Expected return for 2025 is +0.3% - As the only stock from the Magnificent Seven on UBS' list, Amazon is anticipated to benefit from the AI boom and advancements in sports licensing and same-day delivery in its e-commerce operations [8]